Corporate Social Responsibility (CSR) is an integral part of Sanofi’s core business strategy. By building a pragmatic and innovative approach to meet today’s CSR challenges, it contributes to value creation and improving our business.
The Corporate Social Responsibility division, in coordination with the Investor Relations department, is in charge of the information analyzed by socially responsible investors and rating agencies. Both assess companies according to social, environmental, economic and governance criteria.
Rating agencies recognize those companies with proactive policies for responsibly managing economic, environmental and social aspects of doing business, via their indices.
Sanofi is included in the main non-financial rating indices, recognizing our CSR performance.
Our CSR strategy
Healthcare for all
Recognition for our extra-financial performance
Sanofi’s performance is recognized through our inclusion in the most important international Socially Responsible Investment (SRI) indices including:
- Dow Jones Sustainability Index (DJSI) World (Bronze Class): reference index in sustainable Development
- FTSE4Good (Financial Times Stock Exchange)
- Access to Medicine Index (ATM)
- Stoxx® Global ESG Leaders indices
In 2017, Sanofi achieved the UN Global Compact Advanced Level.
The extra-financial scores of Sanofi are presented below:
|Logos||Rating Agencies||Sanofi scores 2017||Sanofi scores 2016|
|CDP Climate Change||A-||A-|
|Global 100 Corporate Knights||22nd||87th|
- Assessment performed every two years.
- #1 of the Pharmaceutical & Biotechnology sector.
- Environmental & Social score 2018.
- 6th out of 151.
Since 2017, Sanofi publishes an Integrated Report based on the International Integrated Reporting Council (IIRC) standards. It presents, in a synthetic manner, the Group’s strategy for creating short, mid- and long-term value (financial and extra-financial) for the company and its stakeholders.
Sanofi also publishes in its French Document de Référence a chapter on Corporate Social Responsibility (Chapter 4) in accordance with Articles L. 225-102-1 and R. 225-104 to R. 225-105-2 of the French Commercial Code relating to companies’ obligations of transparency with regard to Corporate Social Responsibility. An English translation of this chapter is available online.
Our reporting principles are based on the Global Reporting Initiative (GRI) standards, under the “Core” option. Sanofi is also a signatory of the United Nations Global Compact.
In May 2018, Sanofi published its CSR Indicators table and Auditor’s Report, available here.
Other reference documents and factsheets are available in the Documents Center of the “Our Responsibility” section (see below).
2017 Integrated Report
Corporate Social Responsibility
Chapter 4 of the 2017 Document de référence